That deal is completed and 50% went to immune pharmaceutical in Israel and 50% went to immune pharmaceutical in the United States and in fact immune pharmaceutical filed motion to used the proceeds to meet payroll It's done and it's closed .
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.